DavidAlbertoIglesiasMD

Obstetrics & Gynecology • Roanoke, VA

Gynecologic Oncology

Associate Professor, Virginia Tech Carilion School of Medicine

Join to view full profile

Dr. Iglesias is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Iglesias' full profile

Already have an account?

Office
1 Riverside Cir
Roanoke, VA 24016
Is this information wrong?

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2010 - 2014
University of Texas Graduate School of Biomedical SciencesMS, Biomedical Sciences, 2010 - 2012
University of FloridaResidency, Obstetrics and Gynecology, 2006 - 2010
University of Florida College of MedicineClass of 2006

Certifications & Licensure

FL State Medical License 2023 - 2025
VA State Medical License 2014 - 2024
TX State Medical License 2012 - 2016
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Clinical Trials

Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer Start of enrollment: 2019 Feb 27
Recruiting
Phase 1, Phase 2
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) Start of enrollment: 2019 Mar 22
Active, not recruiting
Phase 3
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer Start of enrollment: 2019 Jul 18
Active, not recruiting
Phase 3
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery Start of enrollment: 2020 Aug 25
Recruiting
Phase 3
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer Start of enrollment: 2020 Feb 07
Recruiting
Phase 3
Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer Start of enrollment: 2021 Apr 22
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Dysgerminoma Masquerading as Gestational Trophoblastic Neoplasia.
Conner Blackwell, Shian McLeish, David Iglesias, Shannon D Armbruster> ;Case Reports in Obstetrics and Gynecology. 2023 Jan 1
Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study.
Katherine C Kurnit, Silvana Pedra Nobre, Bryan M Fellman, David A Iglesias, Kristina Lindemann, Anuja Jhingran, Ane Gerda Z Eriksson, Beyhan Ataseven, Gretchen E Glase...> ;Gynecologic Oncology. 2022 Dec 1
2 citations
Endometrial Cancer Characteristics and Risk of Recurrence.
Lindsay E Borden, Tonja M Locklear, Douglas J Grider, Janet L. Osborne, Erin J. Saks, Fidel A. Valea, David A Iglesias> ;American Journal of Clinical Pathology. 2021 Aug 31
18 citations
Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical ...
Abdulrahman K. Sinno, J. Pinkerton, T. Febbraro, N.L. Jones, Namita Khanna, Sarah M. Temkin, David A Iglesias, Bhavana Pothuri> ;Gynecologic Oncology. 2020 Feb 15
1 citations
Venous Thromboembolism Treatment and Prevention in Cancer Patients: Can We Use Pills Yet?
Tulsi Patel, David A. Iglesias> ;Current Treatment Options in Oncology. 2020 Apr 23
36 citations
Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study.
Pamela T. Soliman, Shannon N. Westin, David A Iglesias, Bryan Fellman, Ying Yuan, Qian Zhang, Melinda S. Yates, Russell Broaddus, Brian M. Slomovitz, Karen H. Lu, Robe...> ;Clinical Cancer Research. 2020 Feb 1
Rare Case of Mixed Metastatic Placental Site Trophoblastic Tumor and Choriocarcinoma.
Lindsay E Borden, Elizabeth S McCuin, Pragna D Sheth, David A Iglesias> ;Journal of Oncology Practice. 2019 Jun 17
16 citations
Factors prognostic of survival in advanced-stage uterine serous carcinoma
Laura L. Holman, Navdeep Pal, David A. Iglesias, Pamela T. Soliman, Nyla Balakrishnan, Ann H. Klopp, Russell Broaddus, Nicole D. Fleming, Mark F. Munsell, Karen H. Lu,...> ;Gynecologic Oncology. 2017 Jul 1
1 citations
Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN.
David A. Iglesias, Qian Zhang, Joseph Celestino, Charlotte C. Sun, Melinda S. Yates, Rosemarie Schmandt, Karen H. Lu> ;Oncology. 2017 Jan 1
32 citations
Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study
Pamela T. Soliman, Qian Zhang, Russell Broaddus, Shannon N. Westin, David A. Iglesias, Mark F. Munsell, Rosemarie Schmandt, Melinda S. Yates, Lois M. Ramondetta, Karen...> ;Gynecologic Oncology. 2016 Dec 1
17 citations
Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.
Ngai Na Co, David Iglesias, Joseph Celestino, Suet Ying Kwan, Samuel C. Mok, Rosemarie Schmandt, Karen H. Lu> ;Cancer. 2014 Nov 15
22 citations
The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.
Larissa A. Meyer, Brian M. Slomovitz, Bojana Djordjevic, Shannon N. Westin, David A. Iglesias, Mark F. Munsell, Yunyun Jiang, Rosemarie Schmandt, Russell Broaddus, Rob...> ;International Journal of Gynecological Cancer. 2014 May 1
15 citations
Pelvic exenteration: Impact of age on surgical and oncologic outcomes
Marilyn Huang, David A. Iglesias, Shannon N. Westin, Bryan Fellman, Diana L. Urbauer, Kathleen M. Schmeler, Michael Frumovitz, Pedro T. Ramirez, Pamela T. Soliman> ;Gynecologic Oncology. 2014 Jan 1
58 citations
Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy
David A. Iglesias, Melinda S. Yates, Dharini van der Hoeven, Travis L. Rodkey, Qian Zhang, Ngai Na Co, Jennifer K. Burzawa, Sravanthi Chigurupati, Joseph Celestino, Je...> ;Molecular Cancer Therapeutics. 2013 Dec 1
11 citations
Successful incorporation of robotic surgery into gynecologic oncology fellowship training
Pamela T. Soliman, David A. Iglesias, Mark F. Munsell, Michael Frumovitz, Shannon N. Westin, Alpa M. Nick, Kathleen M. Schmeler, Pedro T. Ramirez> ;Gynecologic Oncology. 2012 Mar 1
34 citations
Chemopreventive effects of metformin on obesity-associated endometrial proliferation
Qian Zhang, Joseph Celestino, Rosemarie Schmandt, Adrienne S. McCampbell, Diana L. Urbauer, Larissa A. Meyer, Jennifer K. Burzawa, Marilyn Huang, Melinda S. Yates, Dav...> ;American Journal of Obstetrics and Gynecology. 2013 Jul 1
2 citations
Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin
C. Craig, David A. Iglesias, Jack L. Watkins, Robert E. Coleman, Larry Kilgore, Pedro T. Ramirez> ;Gynecologic oncology case reports. 2013 Jan 1
4 citations
Personalized care in uterine cancer.
David A. Iglesias, Diane C. Bodurka> ;Clinical advances in hematology & oncology. 2012 Dec 1
9 citations
The effect of body mass index on surgical outcomes and survival following pelvic exenteration.
David A. Iglesias, Shannon N. Westin, Vijayashri Rallapalli, Marilyn Huang, Bryan Fellman, Diana L. Urbauer, Michael Frumovitz, Pedro T. Ramirez, Pamela T. Soliman> ;Gynecologic Oncology. 2012 May 1
133 citations
Understanding obesity and endometrial cancer risk: opportunities for prevention
Rosemarie Schmandt, David A. Iglesias, Ngai Na Co, Karen H. Lu> ;American Journal of Obstetrics and Gynecology. 2011 Dec 1
The search continues: Looking for predictive biomarkers for response mTOR inhibition in endometrial cancer.
Meyer LA, Slomovitz BM, Djordjevic B, Galbincea JM, Johnston TA, Munsell M, Burzawa JK, Huang M, Broaddus R, Iglesias DA, Coleman RL, Gershenson DM, Burke TW, Wolf J, ...> ;J. Clin. Oncol.. 2011-05-20
23 citations
Role of Minimally Invasive Surgery in Staging of Ovarian Cancer
David A. Iglesias, Pedro T. Ramirez> ;Current Treatment Options in Oncology. 2011 Apr 19
3 citations
The effectiveness of endometrial ablation with the Hydro ThermAblator (HTA) for abnormal uterine bleeding.
David A. Iglesias, Shireen Madani Sims, John D. Davis> ;American Journal of Obstetrics and Gynecology. 2010 Jun 1
Join now to see all

Other

Escape to Nature
David Iglesias, MD, Society of Gynecologic Oncology Wellness Blog
https://www.sgo.org/blog/escape-to-nature-david-iglesias-md-ms/
7/24/2021

Committees

Member, Carilion Clinic Obstetrics and Gynecology Residence Program Evaluation Committee 2015 - Present
Member, Virginia Tech Carilion School of Medicine Admissions Committee 2021 - 2022
Member, Society of Gynecologic Oncology Clinical Practice Committee 2018 - 2021
Member, Carilion Clinic Ethics Committee 2015 - 2018